Table 1.
G-CSF | No G-CSF | |
---|---|---|
| ||
N=2142 (%) | N=28,563 (%) | |
Gestational age, weeks | ||
<26 | 480 (22) | 4544 (16) |
26–28 | 751 (35) | 7942 (28) |
29–32 | 524 (24) | 9448 (33) |
33–36 | 230 (11) | 4230 (15) |
≥37 | 155 (7) | 2377 (8) |
Birth weight, g | ||
<1000 | 1170 (55) | 10,929 (38) |
1000–1499 | 463 (22) | 8169 (29) |
1500–2499 | 326 (15) | 6536 (23) |
2500–3499 | 137 (6) | 2150 (8) |
≥3500 | 45 (2) | 751 (3) |
Postnatal age, days | ||
≤7 | 20,768 (73) | 1538 (72) |
8–30 | 3584 (13) | 358 (17) |
>30 | 4211 (15) | 246 (11) |
5-min Apgar score | ||
0–3 | 110 (5) | 1255 (5) |
4–6 | 448 (21) | 4304 (15) |
7–10 | 1533 (73) | 22312 (80) |
Race | ||
White | 1037 (50) | 13,360 (48) |
Black | 526 (25) | 7564 (27) |
Hispanic | 401 (19) | 5305 (19) |
Other | 108 (5) | 1410 (5) |
Small for gestational age | 696 (33) | 6099 (21) |
Male | 1311 (61) | 16948 (59) |
Cesarean section | 1548 (73) | 20436 (72) |
Maternal hypertension* | 356 (17) | 4296 (15) |
Inotropic support† | 640 (30) | 3562 (12) |
Ventilator support† | 1443 (47) | 12,745 (45) |
Concurrent bacteremia | 134 (6) | 1007 (4) |
Maternal hypertension includes preeclampsia, eclampsia and HELLP (hemolysis, elevated liver enzymes, low platelet) syndrome.
On the first day of neutropenia (untreated group) or first day of G-CSF therapy (treated group).